US 9550818
Methods for use of vascular endothelial growth factor antagonists
granted A61KA61K38/1866
Quick answer
US patent 9550818 (Methods for use of vascular endothelial growth factor antagonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/1866